Clinical Trials in Denver

Showing 8061-8080 of 18,161 trials

A Phase 1 Study of Intravesical VAX014 for Instillation in Subjects With Non-Muscle Invasive Bladder Cancer

NCT03854721

The purpose of this research study is to evaluate the safety, tolerability and activity of VAX014 for Instillation (VAX014) in patients with low-grade Non-Muscle Invasive Bladder Cancer (NMIBC). VAX014 is a targeted oncolytic agent designed to kill tumor cells following instillation into the urinary bladder.

Urothelial Carcinoma of the Urinary Bladder

Vaxiion Therapeutics6 participantsStarted May 2019

Denver, Colorado, United States • Iowa City, Iowa, United States • Edison, New Jersey, United States +2 more locations

COMPLETEDNA< 1 mile

The Impact of Co-Dispensing Naloxone to Patients Prescribed Chronic Opioid Therapy

NCT03337100

In the setting of naloxone standing orders, this study will assess if co-dispensing naloxone with opioids to patients prescribed chronic opioid therapy changes opioid risk behaviors, increases naloxone uptake, and increases knowledge about overdose and naloxone.

OverdoseRisk Behavior

Kaiser Permanente7 participantsStarted Nov 2017

Denver, Colorado, United States

COMPLETEDPhase 3< 1 mile

TAC Versus TC for Adjuvant Breast Cancer

NCT00493870

The purpose of this research study is to find out what effects (good and bad) TC or TAC has on early stage HER2- breast cancer.

Breast Cancer

US Oncology Research1,961 participantsStarted May 2007

Birmingham, Alabama, United States • Phoenix, Arizona, United States • Sedona, Arizona, United States +92 more locations

A Phase 1 Study of Intravesical VAX014 for Instillation in Subjects With Non-Muscle Invasive Bladder Cancer

The Impact of Co-Dispensing Naloxone to Patients Prescribed Chronic Opioid Therapy

TAC Versus TC for Adjuvant Breast Cancer

Find Trials by Condition in Denver

A Study of Verinurad and Allopurinol in Patients With Chronic Kidney Disease and Hyperuricaemia

A Study Evaluating the Safety, Tolerability, Pharmacokinetics, and Immunogenicity of Intravitreal Injections of RO7303359 in Participants With Geographic Atrophy Secondary to Age-related Macular Degeneration

Dose Ranging Study of Rimegepant (BMS-927711) for the Acute Treatment of Migraine

Evaluation of the Roadsaver Stent Used in Conjunction With the Nanoparasol Embolic Protection System for Carotid Artery Stenosis

Clinical Trial of Lurbinectedin (PM01183) in Selected Advanced Solid Tumors

An Open-Label, Randomized, Phase 3 Trial of Nivolumab Versus Investigator's Choice Chemotherapy as First-Line Therapy for Stage IV or Recurrent PD-L1+ Non-Small Cell Lung Cancer (CheckMate 026)

Expanded Access Protocol Using 131I-MIBG

Posiphen® Dose-Finding, Biomarker Study in Early Alzheimer's and Parkinson's Patients

Allo vs Hypomethylating/Best Supportive Care in MDS (BMTCTN1102)

Phase 2 Study of Duvelisib in Previously Treated Patients With Chronic Lymphocytic Leukemia /Small Lymphocytic Lymphoma

An Efficacy and Safety Study of Azacitidine Subcutaneous in Combination With Durvalumab (MEDI4736) in Previously Untreated Adults With Higher-Risk Myelodysplastic Syndromes (MDS) or in Elderly Patients With Acute Myeloid Leukemia (AML)

Decitabine With or Without Bortezomib in Treating Older Patients With Acute Myeloid Leukemia

Study to Evaluate the Effects of Fasinumab on Peripheral Nerve Function in Patients With Pain Due to Osteoarthritis of the Hip or Knee

A Safety, Tolerability and Preliminary Efficacy Study of CC-90011 in Combination With Venetoclax and Azacitidine in R/R Acute Myeloid Leukemia and Treatment-naïve Participants Not Eligible for Intensive Therapy

Study to Evaluate the PK of BMS-927711 in Patient With Migraine During Acute Migraine and Non-migraine Condition

A Phase I Study to Assess the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of CT-G20 in Subjects With Obstructive Hypertrophic Cardiomyopathy

Using Peer Support to Aid in Prevention and Treatment in Prediabetes